A I S Resources (OTC:AISSF) Stock, Quote.Headers.trade-ideas

A I S Resources Ltd is an exploration company. It has focused on the evaluation of mineral properties. It acquires prospective exploration projects and enhances their value by defining the mineral resource with a view to attracting joint venture partners and enhancing the value of its portfolio. The company is developing prospective lithium projects in Argentina, and gold projects located in prolific Australian gold mining regions.

Latin America

News

Penny Stocks

Global

Markets

AISSF

GNENF

LTHM

OROCF

SPEYF

Spey Resources is starting a magnetotelluric survey of its Lithium Triangle flagship to identify drill targets and start a resource estimate.

Lithium Explorer To Start Geophysical Survey At Argentina Project

Intraday Update

Movers

Trading Ideas

AAEEF

AAVMY

ABEV

ABGSF

ABMD

ABTX

ACCFF

ACCYY

ACHV

ACNB

ACRFF

ACRGF

ACSAY

ACST

ACTG

ADMA

ADTN

ADVZF

AERI

AFLYY

AGCO

AGEEF

AGESY

AGLXY

AHFD

AHKSY

AHOTF

AICAF

AINV

AIPUY

AIRG

AIRYY

AKO-A

AKZOY

ALDX

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

ALEX

Allianz Ag Muenchen Namen-Akt Vinkuliert Shares

ALIZF

ALLY

ALOT

ALSN

ALTM

ALXEF

ALXN

AMCR

AMHPF

AMKBF

AMKBY

AMNB

AMPH

AMRN

AMSLF

ANAT

ANGO

ANIP

Australia and New Zealand Banking Group Limited

ANZBY

ANZFF

APELY

APEX

APHA

APTS

ARCB

ARCC

ARGGY

ARGO

ARLP

ARNA

ARNGF

AROC

ARREF

ARRRF

Stocks That Hit 52-Week Lows On Friday

A I S Resources Ltd

<a href="https://www.bloomberg.com/news/articles/2024-09-24/meta-to-spurn-eu-s-voluntary-ai-safety-pledge-ahead-of-new-law">https://www.bloomberg.com/news/articles/2024-09-24/meta-to-spurn-eu-s-voluntary-ai-safety-pledge-ahead-of-new-law</a>
&nbsp;
Meta Platforms Inc. is spurning the European Union's voluntary artificial intelligence safety pledge that's planned as a stopgap measure before the bloc's AI Act rules take full force in 2027.

Legal

'Meta To Spurn EU's Voluntary AI Safety Pledge Ahead Of New Law' - Bloomberg News

BlackRock (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/blk#NYSE">BLK</a>) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
The sole determinant of the Zacks rating is a company&#39;s changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.
Since a changing earnings picture is a powerful factor influencing near-term stock price movements, the Zacks rating system is very useful for individual investors. They may find it difficult to make decisions based on rating upgrades by Wall Street analysts, as these are mostly driven by subjective factors that are hard to see and measure in real time.
Therefore, the Zacks rating upgrade for BlackRock basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price.
<h2>Most Powerful Force Impacting Stock Prices</h2>
The change in a company&#39;s future earnings potential, as reflected in earnings estimate revisions, has proven to be strongly correlated with the near-term price movement of its stock. That&#39;s partly because of the influence of institutional investors that use earnings and earnings estimates for calculating the fair value of a company&#39;s shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their transaction of large amounts of shares then leads to price movement for the stock.
For BlackRock, rising earnings estimates and the consequent rating upgrade fundamentally mean an improvement in the company&#39;s underlying business. And investors&#39; appreciation of this improving business trend should push the stock higher.
<h2>Harnessing the Power of Earnings Estimate Revisions</h2>
As empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, tracking such revisions for making an investment decision could be truly rewarding. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988.
<h2>Earnings Estimate Revisions for BlackRock</h2>
For the fiscal year ending December 2024, this investment firm is expected to earn $41.37 per share, which is a change of 9.5% from the year-ago reported number.
Analysts have been steadily raising their estimates for BlackRock. Over the past three months, the Zacks Consensus Estimate for the company has increased 0.3%.
<h2>Bottom Line</h2>
Unlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of &#39;buy&#39; and &#39;sell&#39; ratings for its entire universe of more than 4000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a &#39;Strong Buy&#39; rating and the next 15% get a &#39;Buy&#39; rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
The upgrade of BlackRock to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
<a href="https://www.zacks.com/stock/news/2340060/blackrock-blk-upgraded-to-buy-here-s-what-you-should-know?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2340060">To read this article on Zacks.com click here.</a>

Earnings

Large Cap

Upgrades

Analyst Ratings

BlackRock Upgraded to Buy: Here's What You Should Know

WIIM

MULN

Mullen Automotive shares are trading lower. The company CEO provided shareholders with an update on sales growth, financing, and new vehicle orders.

Intel Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intc#NASDAQ">INTC</a>) shareholders had to bear painful losses throughout this year as the company struggled to make a breakthrough in its stumbling foundry business. However, Intel&#39;s foundry spin-off move, a deal with Amazon.com, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amzn#NASDAQ">AMZN</a>), and a probable QUALCOMM Incorporated&nbsp;takeover boosted its share prices last week.&nbsp;
Does this mean the INTC stock has room to run soon, or is it just a temporary uptick? Is it time to buy the INTC stock, or is it prudent to wait for an opportune moment? Let&#39;s see &ndash;&nbsp;
<h2>Intel Stock Bounces Back</h2>
It&#39;s been a tough year for Intel, with its shares down 57%, in sharp contrast to the Semiconductor - General industry&#39;s gain of 93.3%. Intel has been dealing with costly technological advancements that have led to various cash concerns and compelled the company to suspend dividend payments and cut jobs.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/44/78754.jpg?v=1322943280" style="border-style:solid; border-width:1px" />
Image Source: Zacks Investment Research
Intel&#39;s failure to take advantage of the booming artificial intelligence&nbsp;revolution has also taken a toll on the stock. However, a trifecta of events helped the Intel stock to rebound last week, with the company&#39;s shares soaring more than 11%, its best weekly performance since November.&nbsp;
<h2>What Led to the Rise in Intel Share Prices?</h2>
As per a Wall Street Journal report, Qualcomm has approached Intel for a probable takeover, which should bode well for both companies. Intel manufactures personal computers and server chips, whereas Qualcomm makes mobile products. So, a deal should help both companies to make the most of the other&#39;s strengths and improve market share.
Moreover, Intel has a manufacturing hub that makes its chips. Thus, a potential deal will allow Qualcomm to have its manufacturing facility and not pay for outsourcing, eventually boosting margins.
Intel, meanwhile, has declared a new partnership with Amazon, where Amazon Web Service (AWS) will use Intel&#39;s custom chip designs. Amazon is partnering with Intel for chip design since NVIDIA Corporation&nbsp;has increased its pricing for the e-commerce giant.&nbsp;
The Intel-Amazon deal will help the semiconductor company to regain market share from NVIDIA, which is becoming a worldwide leader in AI.
Lastly, Intel declared it would convert its foundry business into a subsidiary. This is positive news for Intel investors since they were concerned about the company handing over chip designs to industry rivals.&nbsp;
The spin-off would help the struggling foundry business secure funding since this segment hasn&#39;t performed well recently compared to Intel&#39;s design arm. Intel&#39;s foundry business faced stiff competition from Taiwan Semiconductor Manufacturing Company Limited, or TSMC, and reported operating losses in the first half of 2024.
Nevertheless, separating the foundry business would improve Intel&#39;s return on capital deployed. Intel also intends to spend heavily on its foundry business to lure U.S. chipmakers to rely more on domestic manufacturers than foreign companies like TSMC.
<h2>Does Intel&#39;s Strong Week Justify a Buy Decision Today?</h2>
Intel CEO Patrick Gelsinger is banking on the tech deals and separation of the foundry business to improve the bottom line and drive share prices higher. Prominent brokers have also increased the average short-term price target of INTC by 36.1% from the stock&#39;s last closing price of $21.14. Analysts have set the highest price target at $66, an upside of 212.2%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/eb/78755.jpg?v=183965" style="border-style:solid; border-width:1px" />
Image Source: Zacks Investment Research
However, Arm Holdings plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arm#NASDAQ">ARM</a>) has disrupted Intel&#39;s server and networking space. At the same time, Intel has lost ground over its competitor Advanced Micro Devices, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amd#NASDAQ">AMD</a>) which has progressed in manufacturing high-performance processing machinery.
Intel&#39;s current expensive valuation also doesn&#39;t justify its struggles. Per the price/earnings, the INTC stock presently trades at 81.3X forward earnings. However, the industry&#39;s forward earnings multiple is 47.7X.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/64/78756.jpg?v=413786596" style="border-style:solid; border-width:1px" />
Image Source: Zacks Investment Research
Hence, investors should be cautious before buying the INTC stock since it&#39;s still a risky bet. Those invested in the INTC stock should stick to it since the company has a huge upside once it becomes the American version of TSMC, and the recent deals pay off.
The company currently has a Zacks Rank #3 (Hold).
<a href="https://www.zacks.com/stock/news/2340103/3-reasons-why-intel-stock-sealed-a-strong-week-time-to-buy?cid=CS-BENZ-FT-analyst_blog|investment_ideas-2340103">To read this article on Zacks.com click here.</a>

Dividends

Price Target

Tech

AMZN

INTC

3 Reasons Why Intel Stock Sealed a Strong Week: Time to Buy?

Macro Economic Events

Economics

SPDR Dow Jones Industrial Average ETF Trust

Major indexes are higher, rebounding falling earlier consumer sentiment data. Oil, Chinese stocks and NVIDIA have moved higher in Tuesday's session.

Financial giants have made a conspicuous bullish move on Target. Our analysis of options history for Target (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) revealed 11 unusual trades.
Delving into the details, we found 54% of traders were bullish, while 27% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $192,940, and 7 were calls, valued at $359,711.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $110.0 and $185.0 for Target, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Target's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Target's whale trades within a strike price range from $110.0 to $185.0 in the last 30 days. 
<h3>Target 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727196348_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TGT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$1.8</td>
<td>$1.79</td>
<td>$1.8</td>
<td>$180.00</td>
<td>$90.1K</td>
<td>977</td>
<td style="text-align: right;">502</td>
</tr>
<tr>
<td>TGT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$4.25</td>
<td>$4.2</td>
<td>$4.2</td>
<td>$155.00</td>
<td>$84.4K</td>
<td>5.6K</td>
<td style="text-align: right;">235</td>
</tr>
<tr>
<td>TGT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$6.2</td>
<td>$5.9</td>
<td>$6.15</td>
<td>$185.00</td>
<td>$55.7K</td>
<td>235</td>
<td style="text-align: right;">90</td>
</tr>
<tr>
<td>TGT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$8.95</td>
<td>$8.5</td>
<td>$8.5</td>
<td>$160.00</td>
<td>$46.7K</td>
<td>6.1K</td>
<td style="text-align: right;">55</td>
</tr>
<tr>
<td>TGT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$1.61</td>
<td>$1.55</td>
<td>$1.55</td>
<td>$170.00</td>
<td>$46.5K</td>
<td>2.0K</td>
<td style="text-align: right;">672</td>
</tr>
</tbody>
</table>

<h3>About Target</h3>
Target serves as the nation's seventh-largest retailer, with its strategy predicated on delivering a gratifying in-store shopping experience and a wide product assortment of trendy apparel, home goods, and household essentials at competitive prices. Target's upscale and stylish image began to carry national merit in the 1990s—a decade in which the brand saw its top line grow threefold to almost $30 billion—and has since cemented itself as a leading US retailer.Today, Target operates over 1,950 stores in the United States, generates over $100 billion in sales, and fulfills over 2 billion customer orders annually. The firm's vast physical footprint is typically concentrated in urban and suburban markets as the firm seeks to attract a more affluent consumer base.
<h3>Current Position of Target</h3>
<ul>
<li>With a volume of 1,210,121, the price of TGT is up 0.49% at $156.06. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 57 days.</li>
</ul>
<h3>Professional Analyst Ratings for Target</h3>
A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $180.66666666666666.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from JP Morgan persists with their Neutral rating on Target, maintaining a target price of $167. 
&#x2A; Reflecting concerns, an analyst from Melius Research lowers its rating to Buy with a new price target of $180. 
&#x2A; An analyst from Telsey Advisory Group persists with their Outperform rating on Target, maintaining a target price of $195. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Target options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Unpacking the Latest Options Trading Trends in Target

Deep-pocketed investors have adopted a bullish approach towards Humana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in HUM usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 17 extraordinary options activities for Humana. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 58% leaning bullish and 35% bearish. Among these notable options, 8 are puts, totaling $417,304, and 9 are calls, amounting to $508,503.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $250.0 to $350.0 for Humana during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Humana's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Humana's substantial trades, within a strike price spectrum from $250.0 to $350.0 over the preceding 30 days.
<h3>Humana Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727196343_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HUM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$18.2</td>
<td>$17.6</td>
<td>$18.0</td>
<td>$310.00</td>
<td>$126.0K</td>
<td>543</td>
<td style="text-align: right;">78</td>
</tr>
<tr>
<td>HUM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$11.3</td>
<td>$11.2</td>
<td>$11.2</td>
<td>$340.00</td>
<td>$107.5K</td>
<td>290</td>
<td style="text-align: right;">255</td>
</tr>
<tr>
<td>HUM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$53.7</td>
<td>$52.9</td>
<td>$53.65</td>
<td>$350.00</td>
<td>$85.8K</td>
<td>255</td>
<td style="text-align: right;">30</td>
</tr>
<tr>
<td>HUM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$29.0</td>
<td>$28.6</td>
<td>$28.6</td>
<td>$320.00</td>
<td>$85.8K</td>
<td>366</td>
<td style="text-align: right;">30</td>
</tr>
<tr>
<td>HUM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$5.5</td>
<td>$5.4</td>
<td>$5.4</td>
<td>$290.00</td>
<td>$59.9K</td>
<td>1.2K</td>
<td style="text-align: right;">186</td>
</tr>
</tbody>
</table>

<h3>About Humana</h3>
Humana is one of the largest private health insurers in the us with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
After a thorough review of the options trading surrounding Humana, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Humana Standing Right Now?</h3>
<ul>
<li>With a trading volume of 402,787, the price of HUM is up by 0.03%, reaching $312.87.</li>
<li>Current RSI values indicate that the stock is may be oversold.</li>
<li>Next earnings report is scheduled for 36 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Humana</h3>
3 market experts have recently issued ratings for this stock, with a consensus target price of $396.6666666666667.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from RBC Capital has decided to maintain their Outperform rating on Humana, which currently sits at a price target of $400. 
&#x2A; Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Neutral with a new price target of $395. 
&#x2A; An analyst from Cantor Fitzgerald has revised its rating downward to Neutral, adjusting the price target to $395. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Humana with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Looking At Humana's Recent Unusual Options Activity

Whales with a lot of money to spend have taken a noticeably bearish stance on Pfizer.
Looking at options history for Pfizer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) we detected 26 trades.
If we consider the specifics of each trade, it is accurate to state that 46% of the investors opened trades with bullish expectations and 50% with bearish.
From the overall spotted trades, 9 are puts, for a total amount of $523,182 and 17, calls, for a total amount of $1,209,045.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $18.0 and $35.0 for Pfizer, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Pfizer's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Pfizer's significant trades, within a strike price range of $18.0 to $35.0, over the past month.
<h3>Pfizer Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727196338_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PFE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1.32</td>
<td>$1.24</td>
<td>$1.24</td>
<td>$35.00</td>
<td>$344.5K</td>
<td>27.6K</td>
<td>3.2K</td>
</tr>
<tr>
<td>PFE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/18/26</td>
<td>$2.2</td>
<td>$2.15</td>
<td>$2.2</td>
<td>$35.00</td>
<td>$224.7K</td>
<td>1.0K</td>
<td>1.8K</td>
</tr>
<tr>
<td>PFE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$0.85</td>
<td>$0.75</td>
<td>$0.85</td>
<td>$32.50</td>
<td>$127.6K</td>
<td>16.3K</td>
<td>1.5K</td>
</tr>
<tr>
<td>PFE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$6.8</td>
<td>$6.7</td>
<td>$6.7</td>
<td>$35.00</td>
<td>$123.2K</td>
<td>8.7K</td>
<td>300</td>
</tr>
<tr>
<td>PFE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/21/25</td>
<td>$6.75</td>
<td>$6.65</td>
<td>$6.65</td>
<td>$35.00</td>
<td>$79.1K</td>
<td>457</td>
<td>51</td>
</tr>
</tbody>
</table>

<h3>About Pfizer</h3>
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
In light of the recent options history for Pfizer, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is Pfizer Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 8,648,223, the PFE's price is up by 0.19%, now at $29.36. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 35 days.</li>
</ul>
<h3>What Analysts Are Saying About Pfizer</h3>
2 market experts have recently issued ratings for this stock, with a consensus target price of $45.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $45. 
&#x2A; In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $45. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Pfizer with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Pfizer Unusual Options Activity

ENVX

Enovix Option Alert: Oct 18 $10 Calls Sweep (34) Near The Ask: 856 @ $0.34 Vs 17827 OI; Earnings 11/5 After Close [est] Ref=$8.59

Former President Donald Trump recently made a bold promise: if he's elected president again, he'll cut your auto insurance rates in half. But not everyone is buying it and many wonder how he plans to make that happen.
Trump's claim came via a social media post where he said, "Your Automobile Insurance is up 73% – VOTE FOR TRUMP, I'LL CUT THAT NUMBER IN HALF!"&nbsp;
The idea of saving so much money on something as essential as car insurance sounds great, especially with the <a href="https://www.benzinga.com/economics/macro-economic-events/24/05/39001824/janet-yellen-acknowledges-rising-cost-of-living-is-a-problem-to-a-lot-of-people-a">cost of living </a>increasing. However, many experts are scratching their heads over where this 73% figure came from since it doesn't match any recent data.
Don't Miss:
<ul>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li>Can you guess how many retire with a $5,000,000 nest egg? &#8211;<a href="https://www.benzinga.com/money/retire-5mil-nest-egg"> How does it compare to the average?</a></li>
<li>This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes, and you only need $100</a>.</li>
</ul>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Your Automobile Insurance is up 73% — VOTE FOR TRUMP, I'LL CUT THAT NUMBER IN HALF!
&mdash; Donald J. Trump (@realDonaldTrump) <a href="https://twitter.com/realDonaldTrump/status/1836100511960818044?ref_src=twsrc%5Etfw">September 17, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Economist and insurance specialist Robert Hartwig told Insurance Journal that although rates have gone up, they haven&#8217;t increased as much as Trump has claimed. Hartwig claims that while the 73% increase is consistent with September 2016 rates, it does not reflect current trends. In actuality, rates have increased by 16.5% in the last year – a significant increase but nowhere near 73%.
Hartwig and others stress that insurance rates are regulated at the <a href="https://x.com/Bob_Hartwig/status/1836392735261282392">state level</a>, not by the federal government. This means that even if Trump were president, he wouldn't be able to cut insurance rates in half. Instead, he'd have to get 50 state insurance commissioners to agree to his plan – a tall order.
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: Founder of Personal Capital and ex-CEO of PayPal<a href="https://www.benzinga.com/money/evergreen-money"> re-engineers traditional banking with this new high-yield account — start saving better today.</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
Insurance industry experts say that capping rates would hurt consumers in the long run, as Trump suggests. If insurers were forced to lower rates drastically, they'd likely stop offering coverage altogether because they couldn't afford the costs.&nbsp;
On X and other social media websites, many people are skeptical about Trump's promise to cut auto insurance rates in half, wondering how he could possibly make such a big change happen.
One user mocked the feasibility of Trump's plan by tweeting, "This is awesome! We can't wait to see your plan to accomplish this in your first week back on the job!" Others highlighted the irony of his proposal with a comment that read, "Sounds like communism!" given Trump's past criticism of similar ideas from Democrats.
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." <a href="https://www.benzinga.com/money/connect-invest-real-estate-notes">These high-yield real estate notes that pay 7.5% &#8211; 9% make earning passive income easier than ever.</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trump's promise has led some to compare his plan to government price controls, which are widely criticized for creating more problems than they solve. When <a href="https://www.benzinga.com/news/24/08/40387906/kamala-harris-plans-historic-federal-ban-on-corporate-price-gouging-in-food-and-grocery-industries">Kamala Harris suggested capping prices</a> in grocery stores, Trump himself bashed her proposals as "socialist" or "communist."
On the other side, Suze Orman, a well-known financial expert, <a href="https://www.benzinga.com/personal-finance/24/08/40445683/stop-overpaying-suze-orman-reveals-4-essential-steps-to-combat-skyrocketing-car-insurance-rates-">offered some practical advice</a> recently. She suggested that consumers shop around for better deals, raise their deductibles if they have enough savings or even consider owning fewer cars.
Read Next:
<ul>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/red-ventures"> The percentage may shock you</a>.</li>
<li>Are you richer than most people you know?<a href="https://www.benzinga.com/money/are-you-richer-than-most-people"> Here&#8217;s the net worth you need at every age to be above average.</a></li>
</ul>

Personal Finance

Donald Trump Says He'll Cut Your Automobile Insurance In Half. People Push Back And Ask Him If He'll Use Government Price Controls To Do It

ADTX

Aditxt shares are trading lower after its acquisition target Evofem Biosciences filed a preliminary proxy for the stockholder approval of the deal.

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Tuesday.
The Dow traded up 0.07% to 42,156.22 while the NASDAQ rose 0.56% to 18,075.07. The S&amp;P 500 also rose, gaining, 0.21% to 5,730.61.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/09/41000017/how-to-earn-500-a-month-from-nvidia-stock">How To Earn $500 A Month From Nvidia Stock</a>
Leading and Lagging Sectors Materials shares jumped by 1.2% on Tuesday.
In trading on Tuesday, financials shares fell by 0.6%.
Top Headline
Thor Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THO#NYSE">THO</a>) reported better-than-exp earnings for its fourth quarter on Tuesday.
The company reported fourth-quarter earnings per share of $1.68, beating the street view of $1.43. Quarterly sales of $2.534 billion (down 7.4%) outpaced the analyst consensus of $2.471 billion.
Thor Industries said it anticipates fiscal year 2025 sales between $9.0 billion and $9.8 billion, compared to the $10.49 billion estimate, and expects EPS to range from $4.00 to $5.00, below the estimated $6.65.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Maison Solutions Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSS#NASDAQ">MSS</a>) shares shot up 106% to $1.5199 after the company reported a year-over-year increase in first-quarter sales results.</li>
<li>Shares of Seelos Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEEL#NASDAQ">SEEL</a>) got a boost, surging 170% to $0.5130 after the company announced it signed a material transfer agreement to supply SLS-002 for the Department of Defense&#8217;s military and veterans adaptive platform clinical trial for PTSD.</li>
<li>Wave Life Sciences Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WVE#NASDAQ">WVE</a>) shares were also up, gaining 37% to $7.33 after the company announced interim data from its ongoing Phase 2 FORWARD-53 study of WVE-N531 for Duchenne muscular dystrophy.</li>
</ul>
Equities Trading DOWN
<ul>
<li>BioVie Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIVI#NASDAQ">BIVI</a>) shares dropped 53% to $1.31 after the company announced it raised $3 million through a secondary offering of 1.96 million shares at $1.53 per share.</li>
<li>Shares of Laser Photonics Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LASE#NASDAQ">LASE</a>) were down 14% to $16.10. Laser Photonics appointed Robert Hoffman as its new Outside Sales Director.</li>
<li>Light &amp; Wonder, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNW#NASDAQ">LNW</a>) was down, falling 17% to $93.96 after Susquehanna lowered its price target on the stock from $92 to $90.</li>
</ul>
Commodities In commodity news, oil traded up 2% to $71.80 while gold traded up 0.3% at $2,660.00.
Silver traded up 0.9% to $31.355 on Tuesday, while copper rose 3% to $4.4795.
Euro zone
European shares were higher today. The eurozone's STOXX 600 rose 0.58%, Germany's DAX gained 0.63% and France's CAC 40 gained 1.31%. Spain's IBEX 35 Index fell 0.01%, while London's FTSE 100 rose 0.16%.
The Ifo Business Climate indicator for Germany fell to 85.4 in September versus 86.6 in the previous month.
Asia Pacific Markets
Asian markets closed higher on Tuesday, with Japan's Nikkei 225 gaining 0.57%, Hong Kong's Hang Seng Index jumping 4.13%, China's Shanghai Composite Index gaining 4.15% and India's BSE Sensex gaining 0.02%.
The au Jibun Bank Flash Japan composite PMI declined to 52.5 in September compared to a final reading of 52.9 in August.
Economics
<ul>
<li>The S&amp;P CoreLogic Case-Shiller home price index in increased by 5.9% year-over-year in July compared to a 6.5% rise in the previous month.</li>
<li>The FHFA house prices index rose 0.1% in July, compared to market estimates of a 0.2% increase.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/09/40999381/top-4-industrials-stocks-which-could-rescue-your-portfolio-this-quarter">Top 4 Industrials Stocks Which Could Rescue Your Portfolio This Quarter</a></li>
</ul>

Equities

Eurozone

Commodities

BIVI

LASE

Merrill Lynch & Strategic Return Notes for Select 10 Index

SEEL

Nasdaq Surges 100 Points; Thor Industries Earnings Top Views

Canadian <a href="http://benzinga.com/cannabis">cannabis</a> powerhouse Tilray Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>), announced Tuesday that it has launched a new line of hemp-derived Delta-9 THC beverages across key U.S. markets. 
The drinks, set to debut in October, include a range of mocktails, seltzers and sparkling beverages crafted with premium hemp extracts. This move marks Tilray's strategic expansion into the fast-growing <a href="https://www.benzinga.com/topic/cannabis-beverages">hemp-derived THC beverage</a> category.
<ul>
<li>Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe">here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">Tilray Targets Growing Cannabis Beverage Market</h3>
Tilray, already a leader in the cannabis, <a href="http://benzinga.com/topic/hemp">hemp</a> and beverage industries, is leveraging its expertise to meet rising consumer demand for alternative adult beverages. Its new product lineup includes brands like 420 Fizz, Herb &amp; Bloom, Fizzy Jane's and Happy Flower, each with 5mg of Delta-9 THC per can. These products will target a variety of occasions and consumer price points, appealing to diverse audiences.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/08/40509701/hemp-derived-thc-beverages-navigating-regulatory-uncertainty-in-a-potential-13-5b-market">Hemp-Derived THC Beverages: Navigating Regulatory Uncertainty In A Potential $13.5B Market</a>
<h3 class="wp-block-heading">Eyeing Broader Expansion In U.S.</h3>
Tilray's push into the Delta-9 THC space builds on its established presence in the hemp food and craft beer markets. As consumers explore <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40326384/budget-friendly-high-thc-beverages-the-untapped-niche-investors-cant-afford-to-miss">new adult beverage options</a>, the company aims to capture market share by offering a premium, responsibly formulated product experience.&nbsp;
The initial portfolio will roll out in states like <a href="http://benzinga.com/topic/texas-cannabis">Texas</a> and <a href="http://benzinga.com/topic/louisiana-cannabis">Louisiana</a>, with plans for future expansion.
TLRY Price Action TLRY's shares were trading 4.44% higher at $1.76 per share at the time of this writing around noon ET Tuesday.
Related News
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/09/40956859/hemp-derived-products-like-delta-8-thc-are-here-to-stay-says-analyst">Hemp-Derived Products Like Delta-8 THC Are &#8216;Here To Stay,&#8217; Says Analyst</a></li>
<li><a href="https://www.benzinga.com/markets/cannabis/24/09/40945349/cannabis-companies-have-missouris-governor-beat-hemp-thc-products-sales-resume-as-stricter-contr">Cannabis Companies Have Missouri&#8217;s Governor Beat: Hemp-THC Products Sales Resume As Stricter Controls Replace Sweeping Ban</a></li>
</ul>
Image courtesy of Tilray.

Cannabis

Retail Sales

TLRY

Tilray Brands Launches Hemp-Derived Delta-9 THC Drinks In Key U.S. Markets

Guidance

Events

CTVA

Corteva Lowers Top End Of Its 2024 Adjusted EBITDA Estimate

UBER

Watching Uber Technologies; Shares See Volume As Analyst Josh Brown Says He's Bullish On The Co Live On CNBC

Smartsheet Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMAR#NYSE">SMAR</a>) shares are trading higher on Tuesday after funds managed by Blackstone Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>) and Vista Equity Partners disclosed they are acquiring the<a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b41003241/smartsheet-to-be-acquired-by-blackstone-and-vista-equity-partners-for-8-4-billion" rel="noreferrer noopener"> company for around $8.4 billion in cash</a>.
As per the terms, the companies will fully acquire Smartsheet shares for $56.50 per share in cash at the<a target="_blank" href="https://www.benzinga.com/markets/equities/24/09/40750303/blackstone-and-vista-plot-smartsheet-takeover-report" rel="noreferrer noopener"> closing of the proposed transaction</a>.
The price represents a 41% premium over the volume-weighted average closing price of Smartsheet stock for the 90 trading days ending July 17, 2024, and a 16% premium over the highest closing price in the past 12 months.
The Smartsheet Board unanimously supported the deal and recommended that shareholders vote in favor of it at a special meeting.
The merger agreement includes a 45-day &#8220;go-shop&#8221; period, ending on November 8, 2024, during which Smartsheet and its advisors can actively seek alternative acquisition proposals. Smartsheet&#8217;s Board of Directors can terminate the agreement to accept a superior proposal.
The transaction is expected to close in the fourth quarter of Smartsheet&#8217;s fiscal year, ending January 31, 2025, pending shareholder approval, regulatory clearances, and other conditions.
Post deal closure, Smartsheet will become a privately held company, with its Class A common stock delisted, while continuing to operate under its current name and brand.
Blackstone plans to invest in Smartsheet through its flagship private equity vehicle and its private equity strategy tailored for individual investors.
Martin Brand, Head of North America Private Equity and Global Co-Head of Technology Investing at Blackstone, and Sachin Bavishi, a Senior Managing Director at Blackstone, said, &#8220;Across increasingly distributed, cross-functional and global workforces, Smartsheet&#8217;s innovative and market-leading solutions are mission-critical in helping teams collaborate at scale to achieve superior results.&#8221;
&#8220;Modern enterprises rely on Smartsheet&#8217;s simple and scalable solutions to manage a diverse range of business-critical processes every single day because they enable seamless collaboration, enhanced productivity and faster and more informed decision-making,&#8221; stated Monti Saroya, Co-Head of Vista&#8217;s Flagship Fund and Senior Managing Director, and John Stalder, Managing Director at Vista.
This month, Smartsheet reported a second-quarter adjusted EPS of $0.44, surpassing the $0.29 estimate. Sales reached $276.41 million,&nbsp;<a target="_blank" href="https://www.benzinga.com//node/40740114" rel="noreferrer noopener">beating the $274.19 million estimate</a>.
Investors can gain exposure to Smartsheet via Managed Portfolio Series Tremblant Global ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOGA#NYSE">TOGA</a>) and&nbsp;Motley Fool Small-Cap Growth ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/TMFS#BATS">TMFS</a>).
Price Action: SMAR shares are up 6.56% at $55.51 at the last check Tuesday.
Image via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40985822/smartsheet-is-a-smart-buy-for-traders-and-investors-heres-why" target="_blank" rel="noreferrer noopener">Smartsheet Is a Smart Buy for Traders and Investors: Here&#8217;s Why</a></li>
</ul>

Mid Cap

SMAR

TMFS

TOGA

Smartsheet To Be Acquired By Blackstone, Vista In $8.4B Deal: Details

Maison Solutions Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSS#NASDAQ">MSS</a>), a specialty grocery retailer offering traditional Asian and international food, shares are trading higher Tuesday after the company reported its first-quarter financial results after Monday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/24/09/ac40990866/maison-solutions-reports-first-quarter-2025-financial-results">details from the report.&nbsp;</a>
The Details:
Maison Solutions reported $29.6 million in sales for the quarter, up from $13.8 million in the prior year's quarter. Maison said its newly acquired subsidiary, Lee Lee Oriental Supermart, Inc. substantially contributed to the revenue increase, totaling $18.2 million.
The company also reiterated its revenue guidance for fiscal year 2025 of between $120 million and $125 million and expects to be net income positive for the fiscal year. 
Read Next: <a href="https://www.benzinga.com/news/24/09/40991747/snowflake-stock-dips-on-offering-after-hours-what-to-know">Snowflake Stock Dips On Offering After-Hours: What To Know</a>
&#8220;We are pleased with our financial results for Q1 2025, as it marked the first full quarter with Lee Lee included under the Maison Solutions umbrella,&#8221; said John Xu, CEO of Maison Solutions. &#8220;We are encouraged by the immediate financial impact Lee Lee has had across all metrics, importantly, gross margins, which improved from 22.6% in the same quarter last year to 27.9%, getting us closer to the coveted 30% goal for our industry."
According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Maison Solutions shares are trading on heavy volume with more than 77 million shares already traded in Tuesday's session. 
MSS Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Mission Solutions shares are up 90.2% at $1.35 at the time of publication Tuesday.
Read Also:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40991529/what-happened-with-palantir-stock-today">What Happened With Palantir Stock Today?</a></li>
</ul>
Image: Moondance from Pixabay

What's Going On With Maison Solutions Stock After Earnings?

Elliott Sends Second Open Letter to Its Fellow Shareholders
Declares Intent to Call a Special Meeting in Coming Weeks, Given Urgent Need for Leadership Change
Southwest's Use of "False Record Dates" Requires Shareholders Take Action Now to Protect Their Investment
WEST PALM BEACH, Fla., Sept. 24, 2024 /PRNewswire/ -- Elliott Investment Management L.P. ("Elliott"), which manages funds that together have an investment representing an approximately&nbsp;11% economic interest in Southwest Airlines Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>) (the "Company" or "Southwest"), today sent a second open letter to its fellow Southwest shareholders.
In the letter, Elliott Partner John Pike and Portfolio Manager Bobby Xu wrote that although Elliott's goal has been to collaborate with Southwest to restore accountability and best-in-class financial performance, Southwest has chosen a go-it-alone path, featuring a chaotic series of defensive actions, with the goal of obstructing a leadership change that is urgently needed. The letter made clear that Elliott intends to formally call a special meeting in the coming weeks – possibly as soon as next week.
The letter also alerted shareholders to certain defensive actions that Southwest's leaders are taking and urged them to take action to ensure they would be able to vote their shares. Southwest has provided several potential record dates (so-called "false record dates") to banks and brokers in anticipation of Elliott calling a special meeting. The next "false record date" set by Southwest is October 7. Therefore, Elliott strongly urged all Southwest shareholders – especially those who engage in share lending or authorize their brokers to engage in share lending – to work with their banks and brokers as soon as possible to confirm that they are able to vote all their Southwest shares by no later than October 7.

Management

Elliott Issues Letter To Southwest Shareholders, Declares Intent To Call A Special Meeting In Coming Weeks

Visa Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) shares are seeing a drop Tuesday following reports indicating the U.S. Department of Justice (DOJ) is preparing to file an antitrust lawsuit against the <a href="https://www.benzinga.com/markets/equities/24/09/40996656/visa-reportedly-faces-doj-antitrust-lawsuit-alleging-monopolization-of-us-debit-card-market-amid">global payments company.</a>
What To Know: According to Bloomberg, the DOJ is expected to accuse Visa of monopolizing the U.S. debit card market, alleging that the company has engaged in anti-competitive practices, including exclusivity agreements that prevent competitors from entering the space.
The case is the result of years of investigation into Visa&#8217;s business practices, particularly following its failed acquisition attempt of Plaid Inc. in 2021. Additionally, the DOJ has been examining Visa&#8217;s &#8220;tokenization&#8221; technology pricing, which could have also hindered the expansion of rival networks and technology companies looking to enter the market.
This lawsuit is part of a broader regulatory crackdown by the DOJ, which has been targeting monopolistic practices across several industries. The Justice Department has recently been investigating other large tech companies, such as Alphabet and NVIDIA Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), as part of its efforts to curb anti-competitive behavior.
VISA Price Action: Visa&#8217;s stock were down by 4.17% at $276.60 according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://benzinga.slack.com/archives/D072651PB4K/p1722883001180099"><img loading="lazy" decoding="async" width="1024" height="561" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/24112241/VISA-1024x561.png" alt="" class="wp-image-563567" style="width:484px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/24112241/VISA-1024x561.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/24112241/VISA-300x164.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/24112241/VISA-768x421.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/24112241/VISA.png 1078w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
See Also:
<ul>
<li><a href="https://www.benzinga.com/markets/asia/24/09/41003814/chinese-stocks-jump-as-central-bank-unveils-major-stimulus-to-spur-economy-a-step-in-the-right-direc">Chinese Stocks Jump As Central Bank Unveils Major Stimulus To Spur Economy: &#8216;A Step In The Right Direction&#8217;</a></li>
</ul>
Image Via Shutterstock.

NVDA

Visa Shares Are Moving Lower Today: What You Need To Know

Whales with a lot of money to spend have taken a noticeably bearish stance on Newmont.
Looking at options history for Newmont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>) we detected 22 trades.
If we consider the specifics of each trade, it is accurate to state that 31% of the investors opened trades with bullish expectations and 68% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $102,300 and 20, calls, for a total amount of $2,023,989.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $35.0 to $60.0 for Newmont over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for Newmont options trades today is 4825.67 with a total volume of 32,656.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Newmont's big money trades within a strike price range of $35.0 to $60.0 over the last 30 days.
<h3>Newmont 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727195450_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.55</td>
<td>$2.5</td>
<td>$2.51</td>
<td>$60.00</td>
<td>$200.7K</td>
<td>22.3K</td>
<td>7.7K</td>
</tr>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.53</td>
<td>$2.5</td>
<td>$2.5</td>
<td>$60.00</td>
<td>$200.0K</td>
<td>22.3K</td>
<td>2.8K</td>
</tr>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.49</td>
<td>$2.45</td>
<td>$2.46</td>
<td>$60.00</td>
<td>$196.9K</td>
<td>22.3K</td>
<td>3.6K</td>
</tr>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.48</td>
<td>$2.45</td>
<td>$2.46</td>
<td>$60.00</td>
<td>$194.3K</td>
<td>22.3K</td>
<td>3.6K</td>
</tr>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.5</td>
<td>$2.45</td>
<td>$2.45</td>
<td>$60.00</td>
<td>$193.1K</td>
<td>22.3K</td>
<td>5.2K</td>
</tr>
</tbody>
</table>

<h3>About Newmont</h3>
Newmont is the world's largest gold miner. It bought Goldcorp in 2019, combined its Nevada mines in a joint venture with competitor Barrick later that year, and also purchased competitor Newcrest in November 2023. Its portfolio includes 17 wholly or majority owned mines and interests in two joint ventures in the Americas, Africa, Australia and Papua New Guinea. The company is expected to produce roughly 6.9 million ounces of gold in 2024. However, after buying Newcrest, Newmont is likely to sell a number of its higher cost, smaller mines accounting for 20% of forecast sales in 2024. Newmont also produces material amounts of copper, silver, zinc, and lead as byproducts. It had about two decades of gold reserves along with significant byproduct reserves at the end of December 2023.
After a thorough review of the options trading surrounding Newmont, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Newmont's Current Market Status</h3>
<ul>
<li>With a trading volume of 4,370,682, the price of NEM is up by 2.14%, reaching $55.65.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 30 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Newmont</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $61.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Showing optimism, an analyst from Argus Research upgrades its rating to Buy with a revised price target of $58. 
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Buy rating on Newmont with a target price of $65. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Newmont options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Behind the Scenes of Newmont's Latest Options Trends

A.I.S. Resources Limited (TSE:AIS) has released an update. A.I.S. Resources Limited has entered into an option agreement with American Salars Lithi...

AIS Options Lithium Project to American Salars

A.I.S. Resources Limited (TSE:AIS) has released an update. A.I.S. Resources Limited has announced a 1-for-10 reverse stock split effective March 8,...

A.I.S. Resources Initiates Strategic Reverse Split

Ais Resources Ltd (TSE:AIS) has released an update. A.I.S. Resources Limited has announced the strategic appointment of mining entrepreneur John Mc...

AIS Resources Welcomes New Board Member

AIS Resources (TSE:AIS) has released an update. A.I.S. Resources Limited has successfully completed a private placement of convertible debentures w...

A.I.S. Resources Secures Funding Through Private Placement

AIS Resources (TSE:AIS) has released an update. A.I.S. Resources Limited has intensified its gold exploration endeavors in Australia, focusing on t...

AIS Resources Accelerates Australian Gold Exploration

Financing

Press Releases

A.I.S. Resources Options Candela II Interest to American Salars Lithium Inc.

A.I.S. Resources Announces a 1-for-10 Reverse Stock Split

General

A.I.S. to Focus Efforts on Gold Exploration in Australia

A.I.S. Resources Appoints John McCleery to the Board of Directors

A.I.S. Resources Closes Convertible Debenture Private Placement

A.I.S. Resources Sets New Path for Growth with Australian Gold Exploration Update and Board Appointment

CSE:USLI

TSXV:AIS

A I S Resources

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

A I S Resources

A I S Resources (AISSF) Forecast

A I S Resources (OTC:AISSF) Stock, Quote.Headers.trade-ideas